Continuous Ambulatory Peritoneal Dialysis (CAPD) associated peritonitis in a child: A rare case of peritonitis caused by sphingomonous paucimobilis

Journal of the Pakistan Medical Association

Volumn 61, Issue 2, 2011, Pages 178-180

  Tambawala, Arwa Quresh ^a   Hamid, Sadaf ^a   Khan, Iqtidar ^a   Ali, Asad ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

CAPD; Peritonitis; Sphingomonous paucimobilis

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZTREONAM; CATALASE; CEFIXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; MEROPENEM; OFLOXACIN; OXIDOREDUCTASE; POLYMYXIN B; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL PERITONITIS; BACTERIUM CULTURE; BACTERIUM ISOLATION; CASE REPORT; CHILD; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEARING; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; KIDNEY FAILURE; MALE; PERITONEAL FLUID; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRUNE BELLY SYNDROME; SIDE EFFECT; SPHINGOMONAS PAUCIMOBILIS;

ANTI-BACTERIAL AGENTS; CHILD; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONITIS; SPHINGOMONAS; THIENAMYCINS; TREATMENT OUTCOME;

EID: 79251497361     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Krediet RT. 30 years of peritoneal dialysis development: the past and the future. Perit Dial Int 2007; 27: S35-41.
2. Gokal R. Peritoneal dialysis in the 21st century: an analysis of current problems and future developments. J Am Soc Nephrol 2002; 13: S104-16.
3. Munib S. CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD). Gomal J Med Sci 2006; 4: 82-5.
4. Ali Jaffar Naqvi S. Nephrology services in Pakistan. Nephrol Dial Transplant 2000; 15: 769-71.
5. Holley HL, Piraino BM. Complications of peritoneal dialysis: Diagnosis and management. Semin Dial 1990; 3: 245.
6. Stablein DM, Nolph KD, Lindblad AS. Timing and characteristics of multiple peritonitis episodes: a report of the National CAPD Registry. Am J Kidney Dis 1989; 14: 44-9.
7. Burkart JM. Microbiology and therapy of peritonitis in continuous peritoneal dialysis. (Online) 2009 (Cited 2009 Sept). Available from URL: http://www.uptodateonline.com/online/content/topic.do?topicKey=dialysis/2297&selectedTitle=11%7E150&source=search_result.
8. Mujais S. Microbiology and outcomes of peritonitis in North America. Kidney Int Suppl 2006; 103: S55-62.
9. Holmes B, Owen RJ, Evans A, Malnick H, Willcox WR. Pseudomonas paucimobilis, a New Species Isolated from Human Clinical Specimens, the Hospital Environment, and Other Sources. Int J Syst Bacteriol 1977; 27: 133-46.
10. Yabuuchi E, Yano I, Oyaizu H, Hashimoto Y, Ezaki T, Yamamoto H. Proposals of Sphingomonas paucimobilis gen. nov. and comb. nov., Sphingomonas parapaucimobilis sp. nov., Sphingomonas yanoikuyae sp. nov., Sphingomonas adhaesiva sp. nov., Sphingomonas capsulata comb. nov., and two genospecies of the genus Sphingomonas. Microbiol Immunol 1990; 34: 99-119.
11. Hsueh PR, Teng LJ, Yang PC, Chen YC, Pan HJ, Ho SW, et al. Nosocomial infections caused by Sphingomonas paucimobilis: clinical features and microbiological characteristics. Clin Infect Dis 1998; 26: 676-81.
12. Glupczynski Y, Hansen W, Dratwa M, Tielemans C, Wens R, Collart F, et al. Pseudomonas paucimobilis peritonitis in patients treated by peritoneal dialysis. J Clin Microbiol 1984; 20: 1225-6.
13. Dervisoglu E, Meric M, Kalender B, Sengul E. Sphingomonas paucimobilis peritonitis: a case report and literature review. Perit Dial Int 2008; 28: 547-50.
14. Forbes BA, Sahm DF, Weissfeld AS. Bailey & Scott's Diagnostic Microbiology. 12th ed. St. Louis: Mosby Elsevier; 2007.